<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01546168</url>
  </required_header>
  <id_info>
    <org_study_id>GCO 11-0909</org_study_id>
    <nct_id>NCT01546168</nct_id>
  </id_info>
  <brief_title>Deviating the Esophagus in Atrial Fibrillation Ablation</brief_title>
  <official_title>Esophageal Deviation in Atrial Fibrillation Ablation: A Randomized Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vivek Reddy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Icahn School of Medicine at Mount Sinai</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this randomized double-blind study, the investigators would like to compare standard
      practice (i.e., use of luminal esophageal temperature monitoring) to that of esophageal
      deviation during AF ablation. The investigators hypothesize that the strategy of esophageal
      deviation will result in safer ablation strategy with a reduction in the incidence of
      esophageal injury as assessed by endoscopy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Catheter ablation is a commonly performed strategy employed for the treatment of atrial
      fibrillation. However ablation in the posterior wall of the left atrium can cause thermal
      injury to the esophagus. When significant thermal injury to the esophagus occurs, two
      significant complications can occur: 1) the formation of an atrio-esophageal fistula, and 2)
      gastrointestinal dysmotility. While the former is rate, it is an important complication since
      it can be fatal. The frequency of the latter complication is less well appreciated, but
      probably occurs in the range of 1:100 to 1:500. Currently luminal esophageal temperature
      monitoring is the most commonly employed modality to prevent such injury. However, there are
      limitations to its use, and atrio-esophageal fistulas have been reported even when using
      esophageal temperature monitoring. Esophageal deviation using either a TEE or EGD probe has
      been described in the literature, but the effectiveness and practicality of these techniques
      are suboptimal, and have therefore precluded their use in routine clinical practice.
      Recently, we have demonstrated that esophageal deviation is indeed possible using
      off-the-shelf equipment (a soft thoracic tube and endotracheal stylet) in patients undergoing
      AF ablation. In this randomized double-blind study, we will compare standard practice (i.e.,
      use of luminal esophageal temperature monitoring) to esophageal deviation during AF ablation.
      We hypothesize that the strategy of esophageal deviation will result in safer ablation
      strategy with a reduction in the incidence of esophageal injury as assessed by endoscopy.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Interim analysis: no statistically significant difference in the 2 study arms.
  </why_stopped>
  <start_date>November 2011</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Presence of Esophageal Injury</measure>
    <time_frame>within 1 week of AF ablation procedure</time_frame>
    <description>The presence of esophageal injury as assessed by upper gastrointestinal endoscopy that is performed within 1 week of the procedure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Procedure Time</measure>
    <time_frame>day 1, duration ofAF ablation procedure</time_frame>
    <description>Procedure time and fluoroscopic imaging with barium contrast time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Temperature</measure>
    <time_frame>during AF ablation procedure (intraoperative)</time_frame>
    <description>Extent of temperature rise on the temperature monitoring probe</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Swallowing Impairment Score</measure>
    <time_frame>during AF ablation procedure (intraoperative)</time_frame>
    <description>Swallowing impairment during procedure - Scale from 0 (no impairment) to 4 (severe impairment).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">88</enrollment>
  <condition>Esophageal Deviation</condition>
  <condition>Atrial Fibrillation</condition>
  <condition>Ablation</condition>
  <arm_group>
    <arm_group_label>esophageal deviation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>esophageal deviation with IDE device during AF ablation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>temperature monitoring</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>luminal esophageal temperature monitoring, standard temperature monitoring alone</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>esophageal deviation with IDE device</intervention_name>
    <description>esophageal deviation during AF ablation</description>
    <arm_group_label>esophageal deviation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;18 - Age &lt; 80 yr

          -  Documentation of atrial fibrillation (AF)

          -  Referred for a first ever ablation procedure for AF (prior ablation of right-sided
             Typical flutter, or &quot;limited&quot; left-sided of an accessory pathway are permitted)

          -  General anesthesia

          -  All patients must understand and adhere to the requirements of the study and be
             willing to comply with the post study follow-up requirements.

        Exclusion Criteria:

          -  Any reversible cause of AF (post-surgery, thyroid disorder, etc.)

          -  INR &gt; 4.0 at the time of the procedure

          -  H/o of severe esophageal ulcers, strictures, esophagitis or GERD

          -  H/o Esophageal Surgery

          -  Prior surgical or catheter ablation procedure for AF (except right atrial flutter
             ablation)

          -  Any evidence of esophageal diverticulum or other structural abnormalities of the
             esophagus seen during baseline barium esophagogram

          -  Significant abnormality on Swallowing Impairment Score

          -  Mental impairment precluding signing consent or completing follow up

          -  Patients with any other significant uncontrolled or unstable medical condition

          -  Women who are known to be pregnant or have had a positive Î²-HCG test 7 days prior to
             procedure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vivek Reddy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Florida Hospital</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Cardiac Arrhythmia Institute</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78075</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 13, 2012</study_first_submitted>
  <study_first_submitted_qc>March 1, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 7, 2012</study_first_posted>
  <results_first_submitted>April 17, 2017</results_first_submitted>
  <results_first_submitted_qc>January 19, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">January 23, 2018</results_first_posted>
  <last_update_submitted>January 19, 2018</last_update_submitted>
  <last_update_submitted_qc>January 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Icahn School of Medicine at Mount Sinai</investigator_affiliation>
    <investigator_full_name>Vivek Reddy</investigator_full_name>
    <investigator_title>Director Cardiac Arrhythmia Service, Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Atrial Fibrillation ablation</keyword>
  <keyword>Esophageal Deviation</keyword>
  <keyword>AF</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment began in November 2011, with enrollment beginning February 2012</recruitment_details>
      <pre_assignment_details>88 participants were consented, but 2 withdrew prior to randomization</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Esophageal Deviation</title>
          <description>esophageal deviation with IDE device during AF ablation</description>
        </group>
        <group group_id="P2">
          <title>Temperature Monitoring</title>
          <description>luminal esophageal standing temperature monitoring alone</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="55"/>
                <participants group_id="P2" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="51"/>
                <participants group_id="P2" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>ineligible after signing consent</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>17 roll-in patients and two pre-procedure withdrawals are removed from the analysis</population>
      <group_list>
        <group group_id="B1">
          <title>Esophageal Deviation</title>
          <description>esophageal deviation with IDE device during AF ablation</description>
        </group>
        <group group_id="B2">
          <title>Temperature Monitoring</title>
          <description>luminal esophageal standing temperature monitoring alone</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="36"/>
            <count group_id="B2" value="33"/>
            <count group_id="B3" value="69"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.8" spread="8.3"/>
                    <measurement group_id="B2" value="62.6" spread="8.6"/>
                    <measurement group_id="B3" value="61.7" spread="8.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="18"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Persistent AF</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Paroxysmal AF</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>CHADS Score</title>
          <description>CHADS score for Stroke Risk Assessment in Atrial Fibrillation CHADS is a mnemonic for Congestive Heart Failure, Hypertension, Age over 75 years, Diabetes Mellitus, and Stroke or TIA history CHADS Score &gt;2 (CVA risk &gt;5% per year) CHADS Score 1 (CVA risk &gt;4% per year) CHADS Score 0 (low risk)</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.7" spread="0.8"/>
                    <measurement group_id="B2" value="1" spread="0.9"/>
                    <measurement group_id="B3" value="0.83" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>History of GERD</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Presence of Esophageal Injury</title>
        <description>The presence of esophageal injury as assessed by upper gastrointestinal endoscopy that is performed within 1 week of the procedure.</description>
        <time_frame>within 1 week of AF ablation procedure</time_frame>
        <population>17 roll-in patients and two pre-procedure withdrawals are removed from the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Esophageal Deviation</title>
            <description>esophageal deviation with IDE device during AF ablation</description>
          </group>
          <group group_id="O2">
            <title>Temperature Monitoring</title>
            <description>luminal esophageal standing temperature monitoring alone</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Presence of Esophageal Injury</title>
          <description>The presence of esophageal injury as assessed by upper gastrointestinal endoscopy that is performed within 1 week of the procedure.</description>
          <population>17 roll-in patients and two pre-procedure withdrawals are removed from the analysis.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Procedure Time</title>
        <description>Procedure time and fluoroscopic imaging with barium contrast time</description>
        <time_frame>day 1, duration ofAF ablation procedure</time_frame>
        <population>17 roll-in patients and two pre-procedure withdrawals are removed from the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Esophageal Deviation</title>
            <description>esophageal deviation with IDE device during AF ablation</description>
          </group>
          <group group_id="O2">
            <title>Temperature Monitoring</title>
            <description>luminal esophageal standing temperature monitoring alone</description>
          </group>
        </group_list>
        <measure>
          <title>Procedure Time</title>
          <description>Procedure time and fluoroscopic imaging with barium contrast time</description>
          <population>17 roll-in patients and two pre-procedure withdrawals are removed from the analysis.</population>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Fluoroscopy time</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="21.1" spread="9.9"/>
                    <measurement group_id="O2" value="20.9" spread="18.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Procedure duration</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.39" spread="1.00"/>
                    <measurement group_id="O2" value="4.11" spread="1.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Temperature</title>
        <description>Extent of temperature rise on the temperature monitoring probe</description>
        <time_frame>during AF ablation procedure (intraoperative)</time_frame>
        <population>17 roll-in patients and two pre-procedure withdrawals are removed from the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Esophageal Deviation</title>
            <description>esophageal deviation with IDE device during AF ablation</description>
          </group>
          <group group_id="O2">
            <title>Temperature Monitoring</title>
            <description>luminal esophageal standing temperature monitoring alone</description>
          </group>
        </group_list>
        <measure>
          <title>Temperature</title>
          <description>Extent of temperature rise on the temperature monitoring probe</description>
          <population>17 roll-in patients and two pre-procedure withdrawals are removed from the analysis.</population>
          <units>Celsius</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.26" spread="0.2"/>
                    <measurement group_id="O2" value="1.1" spread="0.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Swallowing Impairment Score</title>
        <description>Swallowing impairment during procedure - Scale from 0 (no impairment) to 4 (severe impairment).</description>
        <time_frame>during AF ablation procedure (intraoperative)</time_frame>
        <population>17 roll-in patients and two pre-procedure withdrawals are removed from the analysis.</population>
        <group_list>
          <group group_id="O1">
            <title>Esophageal Deviation</title>
            <description>esophageal deviation with IDE device during AF ablation</description>
          </group>
          <group group_id="O2">
            <title>Temperature Monitoring</title>
            <description>luminal esophageal standing temperature monitoring alone</description>
          </group>
        </group_list>
        <measure>
          <title>Swallowing Impairment Score</title>
          <description>Swallowing impairment during procedure - Scale from 0 (no impairment) to 4 (severe impairment).</description>
          <population>17 roll-in patients and two pre-procedure withdrawals are removed from the analysis.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="36"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.67" lower_limit="0" upper_limit="4"/>
                    <measurement group_id="O2" value="0.27" lower_limit="0" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>17 roll-in patients and two pre-procedure withdrawals are removed from the analysis.</desc>
      <group_list>
        <group group_id="E1">
          <title>Esophageal Deviation</title>
          <description>esophageal deviation with IDE device during AF ablation</description>
        </group>
        <group group_id="E2">
          <title>Temperature Monitoring</title>
          <description>luminal esophageal standing temperature monitoring alone</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Pericardial Effusion</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Asthma Exacerbation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Atrial Flutter</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Venous Thrombophlebitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Atrial Fibrillation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nausea with abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Groin Hematoma</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Urinary Tract Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="36"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Vivek Y Reddy</name_or_title>
      <organization>Icahn School of Medicine at Mount Sinai</organization>
      <phone>212-241-7114</phone>
      <email>vivek.reddy@mountsinai.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

